Author of

• 33736

  +

  D02 - Optimal therapy for stage 4 NSCLC patient with low PD-L1 expression (1-49%) (ID D02)

  • Event: TTLC 2020
  • Type: General Session
  • Track:
  • Presentations: 1
  • Moderators:
  • Coordinates: 2/20/2020, 15:20 - 15:35,

  • 33975

    +

    Chemo + PD-1 inhibition (ID D02.01)

    15:20 - 15:35  |  Author(s): Karen Reckamp
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

• 33732

  +

  S01 - EGFR TKI's (ID S01)

  • Event: TTLC 2020
  • Type: General Session
  • Track:
  • Presentations: 1
  • Moderators:
  • Coordinates: 2/20/2020, 07:30 - 09:45,

  • 33759

    +

    Zn-e4 (ID S01.02)

    07:30 - 09:45  |  Author(s): Karen Reckamp
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.